Working to Eradicate Gynecologic Cancers

388
The impact of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts

Sunday, March 29, 2015: 7:00 AM
Salon C-D (Hilton Chicago)
M. AlHilli, J. N. Bakkum-Gamez, A. Mariani, V. Shridhar, B. A. Cliby, M. McGree, A. L. Weaver, S. C. Dowdy and K. C. Podratz
Mayo Clinic, Rochester, MN